FDAHealthJanuary 29, 2026
Teva Pharmaceuticals USA, Inc — Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceutic
⚠️ Failed Dissolution Specifications
Is this relevant to me?
- Geography
- Nationwide
- Source agency
- FDA
- Category
- Health
- Published
- January 29, 2026
Nationwide
What's affected?
- Product
- Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054.
- Brand
- METOPROLOL SUCCINATE
- Lot code
- a)
Additional details
Lot#: a) 0718J251, 0729J251, 0730J251, Exp.: 12/2026; b) 0718J252, 0729J252, 0730J252, Exp.: 12/2026.
What should I do?
Recommended action
Class II recall. Voluntary: Firm initiated Quantity affected: 7,448 bottles.
Get Health recall alerts
Delivered to your inbox. Free. No account required.